GNAS and neoplasm: Comparing the clinical and laboratory characteristics of patients with somatotropinomas harboring (+) or not (−) GNAS mutations, no significant difference was identified in gender, age of diagnosis, tumor size and extension, and hormonal and tumor remission (Table 2).